Oxygen diffusive wound dressings and methods of manufacturing and use are described herein. The wound dressing may generally provide a ready supply of oxygen to a wound being treated via one or more oxygen conduits which are designed to pass oxygen from ambient air or other oxygen reservoirs into proximity to the wound, and may also provide for exudate removal through transecting channels in fluid communication with both the wound surface and a hydrophilic absorbent material.

A bandage for use at an aggressive bleeding site of a patient is disclosed. The bandage includes a stretchable wrap, an auxiliary strap, a primary absorbent body, and at plural secondary absorbent bodies. The primary absorbent body is located on the inner surface of the wrap. The wrap is arranged to be wrapped about and tightly encircle a portion of the body of a patient at which the bleeding site is located to cause the primary absorbent body to apply pressure thereto. The auxiliary strap is secured to the wrap and is normally held in stowed position on the wrap, but arranged to be moved to an extended position whereupon the secondary absorbent bodies overlies said primary absorbent body and apply pressure thereto and to the underlying aggressive bleeding site.

A dressing or device to distribute pressure for the purpose of prevention and treatment of wounds and intact skin is provided. The pressure distributing properties are achieved by a closed cell foam material that is in direct contact with the intact skin or wound and that can also have the ability to manage and absorb moisture. These unique characteristics creates a flexible, and easy to use dressing that can be cut to size and applied to any desired location on a patient.

The disclosure provides methods of treating a wound using negative pressure wound therapy by contacting a wound with a porous fibrin foam dressing and applying negative pressure on the wound, wherein the fibrin foam includes a three-dimensional reaction product of fibrinogen and thrombin and is biodegradable in vivo. Further provided is a dressing material for negative pressure wound therapy comprising a porous fibrin foam that can substantially conform to a shape of the wound, wherein the fibrin foam includes a three-dimensional reaction product of fibrinogen and thrombin, is biodegradable in vivo, and does not need to be changed during the course of therapy.

The present invention relates to a negative pressure wound closure system and methods for using such a system. Preferred embodiments of the invention facilitate closure of the wound by preferentially contracting to provide for movement of the tissue.

A bioresorbable haemostatic foam sponge for adhering to a wound. The sponge has a tissue-contacting surface divided into a plurality of closely-spaced tissue contacting elements. Also disclosed are methods for forming the haemostatic sponge and methods of using the sponge.

The present invention generally relates to dressings such as bandages or tapes having improved extensibility and conformability to human skin and joints.

The present invention generally relates to dressings such as bandages or tapes having improved extensibility and conformability to human skin and joints.

A wound healing device and method that greatly reduces the risk of infection of an incision or wound by removing fluid from the subcutaneous skin layers. The wound healing device includes a first portion that is positioned external of, and on top of, the wound. At least one strip, cord, finger, member is in fluid communication at one end with the first portion while the second free end of the at least one strip, cord, finger, member is pushed down into the wound, in between the sutures or staples of a closed incision. Both the first portion and the at least one strip comprise fluid absorbable material for absorbing the wound fluid. The device remains in place for approximately 1-3 days after which it is removed. Upon removal, natural temporary type of fistulae are formed in the subcutaneous skin layers to continue draining wound fluids outward for another 1-2 days.

A negative pressure wound closure system and methods for using such a system are described. Preferred embodiments of the invention facilitate closure of the wound by preferentially contracting to provide for movement of the tissue. Some embodiments may include wound closure devices built from smaller units that are modular, assemble-able and/or customizable.